Buy Immune Pharmaceuticals Stock | IMNP Stock Price & Latest News | Public
IMNP

Immune Pharmaceuticals

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About IMNP

    Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eos...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$818,5k
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$0.01
    1 Year Low$0.00
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app